Use of indolyl and indolinyl hydroxamates for treating neurodegenerative disorders or cognitive decicits
AssigneeTaipei Medical University
InventorKuo Sheng Hung
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel use of indolyl and indolinyl hydroxamates. Particularly, the invention relates to use of indolyl and indolinyl hydroxamates in the manufacturing a medicament or a pharmaceutical composition for treating a ischemic and hemorrhagic stroke, spinal cord injury, cranial nerve injury, peripheral nerve injury and a neurodegenerative disorder or cognitive deficit.
Claims11
A method for reducing neuronal loss and increasing locomotor function after spinal cord injury in a subject, comprising administering to the subject a therapeutically effective amount of the compound having formula (I),
- wherein is a single or double bond;
- B is SO2R;
- C is H;
- Xa, Xc and Xd are H;
- Xb is CH═CHC(O)NHOH;
- and R is H, alkyl, alkenyl, alkynyl, aryl, or heteroaryl
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.